Search research articles
Contact Us
Filters
Showing results (321-330 of 342) with videos related to
Page
of 35
Sort By:
European Journal of Medical Genetics
|
September 15, 2010
Cytogenetic molecular delineation of a terminal 18q deletion suggesting neo-telomere formation
Leslie Domenici Kulikowski, Maisa Yoshimoto, Fernanda Teixeira da Silva Bellucco, et al.
Cancer Genetics
|
June 12, 2012
Multiple CDK/CYCLIND genes are amplified in medulloblastoma and supratentorial primitive neuroectodermal brain tumor
Meihua Li, Will Lockwood, Maria Zielenska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2008
Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21
Chang-Qi Zhu, Gilda da Cunha Santos, Keyue Ding, et al.
The Prostate
|
May 3, 2026
Impact of Genomic Mutations on the Transcriptional Pathways and Tumor Microenvironment Landscape of Localized Early Prostate Cancer
William Lautert-Dutra, Camila M Melo, Luiz P Chaves, et al.
American Journal of Medical Genetics. Part A
|
February 27, 2010
A rare case of trisomy 15pter-q21.2 due to a de novo marker chromosome
Ade Nubia Xavier Pacanaro, Denise Maria Christofolini, Leslie Domenici Kulikowski, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
September 13, 2005
An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line
Yuwei Wang, Hui Xue, Jean-Claude Cutz, et al.
Investigational New Drugs
|
May 19, 2015
A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195
B J Eigl, S North, E Winquist, et al.
The Journal of Pathology. Clinical Research
|
December 6, 2016
STAT1-associated intratumoural T<sub>H</sub>1 immunity predicts chemotherapy resistance in high-grade serous ovarian cancer
Katrina K Au, Cécile Le Page, Runhan Ren, et al.
Urologic Oncology
|
February 4, 2024
Germline variants in early and late-onset Brazilian prostate cancer patients
Karoline Brito Caetano Andrade Coelho, Jeremy A Squire, Kelly Gomes Duarte, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 7, 2015
Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity
Mona Meyer, Jüri Reimand, Xiaoyang Lan, et al.
Page
of 35
Search research articles
Search
Showing results (321-330 of 342) with videos related to
Sort By:
Page
of 35
European Journal of Medical Genetics
|
September 15, 2010
Cytogenetic molecular delineation of a terminal 18q deletion suggesting neo-telomere formation
Leslie Domenici Kulikowski, Maisa Yoshimoto, Fernanda Teixeira da Silva Bellucco, et al.
Cancer Genetics
|
June 12, 2012
Multiple CDK/CYCLIND genes are amplified in medulloblastoma and supratentorial primitive neuroectodermal brain tumor
Meihua Li, Will Lockwood, Maria Zielenska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2008
Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21
Chang-Qi Zhu, Gilda da Cunha Santos, Keyue Ding, et al.
The Prostate
|
May 3, 2026
Impact of Genomic Mutations on the Transcriptional Pathways and Tumor Microenvironment Landscape of Localized Early Prostate Cancer
William Lautert-Dutra, Camila M Melo, Luiz P Chaves, et al.
American Journal of Medical Genetics. Part A
|
February 27, 2010
A rare case of trisomy 15pter-q21.2 due to a de novo marker chromosome
Ade Nubia Xavier Pacanaro, Denise Maria Christofolini, Leslie Domenici Kulikowski, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
September 13, 2005
An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line
Yuwei Wang, Hui Xue, Jean-Claude Cutz, et al.
Investigational New Drugs
|
May 19, 2015
A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195
B J Eigl, S North, E Winquist, et al.
The Journal of Pathology. Clinical Research
|
December 6, 2016
STAT1-associated intratumoural T<sub>H</sub>1 immunity predicts chemotherapy resistance in high-grade serous ovarian cancer
Katrina K Au, Cécile Le Page, Runhan Ren, et al.
Urologic Oncology
|
February 4, 2024
Germline variants in early and late-onset Brazilian prostate cancer patients
Karoline Brito Caetano Andrade Coelho, Jeremy A Squire, Kelly Gomes Duarte, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 7, 2015
Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity
Mona Meyer, Jüri Reimand, Xiaoyang Lan, et al.
Page
of 35